TechFlow news, November 8 — Quantum BioPharma (Nasdaq: QNTM) today announced its third-quarter 2025 financial results, showing a significant improvement in its financial position, with shareholders' equity increasing by 275% quarter-over-quarter, total liabilities reduced by 50%, and debt-to-equity ratio down by 87%. The company's digital asset portfolio (primarily Bitcoin) has realized a gain of $572,000, with the total value of digital assets rising from $800,000 at the end of 2024 to the current $5.2 million.
Navigating Web3 tides with focused insights
Contribute An Article
Media Requests
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号




